Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Auto Casualty
White Paper
Three Ways to Eliminate Chaos in the Auto Casualty Claims Process
Workers' Comp
Article
Ask The Pharmacist: CGRP Therapies for Migraine Management in Workers' Compensation
How can CGRP therapies improve outcomes in workers’ compensation migraine claims?Migraines affect around one
Workers' Comp
Article
Migraine Medication Trends in Work Comp
Join Tom Kerr as he interviews Nikki Wilson, Senior Director of Clinical Pharmacy Services to dig into part one of our
Workers' Comp
Podcast
Calculating the Value of Evidence-Based PT
Workers' Comp
Conference
Workers’ Compensation Institute (WCI) 2025 Conference
Enlyte is proud to return as an Elite Sponsor at the 2025 Workers' Compensation Institute (WCI) Conference in Orlando, Florida—th
Workers' Comp
Article
Reclaim Control Over Specialty Costs
The Growing Surge in Specialty Service CostsAs specialty services become a major driver of rising expenses, effective management of medica